Ditchcarbon
  • Contact
  1. Organizations
  2. Piramal Pharma Solutions Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated 20 days ago

Piramal Pharma Solutions Inc.

Company website

Piramal Pharma Solutions Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates across key regions including North America, Europe, and Asia. Founded in 2004, the company has established itself as a leader in contract development and manufacturing, offering a comprehensive range of services from drug discovery to commercial manufacturing. With a focus on providing innovative solutions, Piramal Pharma Solutions is renowned for its expertise in complex formulations and advanced drug delivery systems. The company’s commitment to quality and customer-centric approach has earned it a strong market position, making it a preferred partner for pharmaceutical and biotechnology companies worldwide. Notable achievements include significant collaborations and a robust portfolio of core products that cater to diverse therapeutic areas, underscoring its role as a vital contributor to the global healthcare landscape.

DitchCarbon Score

How does Piramal Pharma Solutions Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

58

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Piramal Pharma Solutions Inc.'s score of 58 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

76%

Let us know if this data was useful to you

Piramal Pharma Solutions Inc.'s reported carbon emissions

Inherited from Piramal Enterprises Limited

Piramal Pharma Solutions Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Piramal Enterprises Limited, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or specific climate pledges from Piramal Pharma Solutions Inc., it is important to note that emissions data and performance metrics may be inherited from its parent company, Piramal Enterprises Limited. This cascading of data occurs at a level 3 relationship, suggesting that any climate initiatives or targets may be aligned with those set by Piramal Enterprises Limited. As of now, Piramal Pharma Solutions Inc. has not publicly committed to specific science-based targets or initiatives under frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The absence of these commitments highlights a potential area for growth in their sustainability strategy, particularly in the context of increasing industry standards for climate action and transparency.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
40,881,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
86,928,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Piramal Pharma Solutions Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Piramal Pharma Solutions Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Piramal Pharma Solutions Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lonza

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Akums Drugs and Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Catalent

US
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Gland Pharma

IN
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Recipharm

SE
•
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251002.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy